Cargando…

Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study

OBJECTIVE: Given the high rates of cardiovascular disease (CVD) and associated mortality in individuals with type 2 diabetes, identifying and understanding predictors of CVD events and mortality could help inform clinical management in this high-risk group. Recent large-scale genetic studies may pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Amanda J., Hsu, Fang-Chi, Ng, Maggie C.Y., Langefeld, Carl D., Freedman, Barry I., Carr, J. Jeffrey, Bowden, Donald W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178326/ https://www.ncbi.nlm.nih.gov/pubmed/24574349 http://dx.doi.org/10.2337/dc13-1514

Ejemplares similares

Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
por: Chan, Gary C., et al.
Publicado: (2018)

Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes
por: Freedman, Barry I., et al.
Publicado: (2015)

Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study
por: Raffield, Laura M, et al.
Publicado: (2013)

Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2021)

Analysis of common and coding variants with cardiovascular disease in the diabetes heart study
por: Adams, Jeremy N, et al.
Publicado: (2014)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population
por: Yap, Jonathan, et al.
Publicado: (2021)

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
por: Lu, Jingyi, et al.
Publicado: (2021)

Metabolic Syndrome and All-Cause and Cardiovascular Mortality in an Italian Elderly Population: The Progetto Veneto Anziani (Pro.V.A.) Study
por: Zambon, Sabina, et al.
Publicado: (2009)

Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR)
por: Riise, Hilde Kristin Refvik, et al.
Publicado: (2021)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019)

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study
por: An, Yali, et al.
Publicado: (2015)

Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis
por: Gujral, Unjali P, et al.
Publicado: (2021)

Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Hispanic representation in diabetes cardiovascular outcomes trials
por: Kelley, A. Taylor, et al.
Publicado: (2019)

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study
por: Anjana, Ranjit Mohan, et al.
Publicado: (2020)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women
por: Yoshida, Yilin, et al.
Publicado: (2021)

Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong
por: Lee, Sharen, et al.
Publicado: (2021)

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
por: Davis, Stephen N., et al.
Publicado: (2019)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
por: Bergmark, Brian A., et al.
Publicado: (2018)

Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study
por: Hamdy, Osama, et al.
Publicado: (2017)

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014)

Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
por: DeBoer, Mark D., et al.
Publicado: (2018)

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
por: Berg, David D., et al.
Publicado: (2021)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Diabetes and infectious disease mortality in Mexico City
por: Bragg, Fiona, et al.
Publicado: (2023)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria
por: Hyvärinen, Marjukka, et al.
Publicado: (2009)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
por: Shah, Hetal S., et al.
Publicado: (2018)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
por: Devers, Marion C, et al.
Publicado: (2016)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function
por: Roes, Stijntje D., et al.
Publicado: (2008)

Association of physiological and psychological health outcomes with physical activity and sedentary behavior in adults with type 2 diabetes
por: Garcia, Jeanette M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1me0fc15rogk7bs8il3dbm21ap